Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Genistein Inhibits the Proliferation of MDA-MB-231 Cells In Vivo

  • Kim, Yoo-Kyeong (Department of Home Economics Education, Kyungpook National University) ;
  • Kim, Hyeon-A (Major in Food & Nutrition, Mokpo National University) ;
  • Park, Min-Young (Major in Food & Nutrition, Mokpo National University) ;
  • Do, Sun-Hee (Department of Veterinary Pathology, College of Veterinary Medicine, Kyungpook National University)
  • Published : 2007.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study was conducted to evaluate the influence of diets containing genistein and soy extract on the growth of MDA-MB-231 cells implanted into female Balb/c mice. Four-week-old female athymic nude mice (Balb/c) were acclimated to an AIN-93G control diet for 1 week and then injected MDA-MB-231 cells ($1{\times}10^6$/site) and were continued on the on AIN-93G control diet. Five weeks after injecting the MDA-MB-231 cells ($1{\times}10^6$/site), two experimental groups were assigned to diets containing genistein (750 ${\mu}g/g$ AIN-93G diet) or 0.6% soy extract (containing genistein at 750 ${\mu}g/g$ AIN-93G diet) until they were sacrificed. Tumor growth was significantly reduced in the groups treated with genistein and soy extract compared to the control group. The results of the proliferating cell nuclear antigen (PCNA) assay also revealed that genistein and soy extract treatment reduced the proliferation of MDA-MB-231 cells in vivo. In the present study, dietary isoflavone was provided just before solid tumor formation, and thus the timing of dietary isoflavone administration may be critical to the suppression of tumor growth.

Keywords

References

  1. Ferlay J, Bray F, Pisani P, Parkin DM. 2001. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. IARC Press, Lyon
  2. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. 1991. Dietary effects on breast-cancer risk in Singapore. Lancet 337: 1197-1200 https://doi.org/10.1016/0140-6736(91)92867-2
  3. National Research Council. 1994. Strategies for improving risk assessment. In Science and judgment in risk assess-ment. National Academy Press, Washington DC. p 79-84
  4. Barnes S. 1998. Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 12: 559-579 https://doi.org/10.1016/S0950-351X(98)80004-9
  5. Dixon RA, Ferreira D. 2002. Genistein. Phytochemistry 60: 205-211 https://doi.org/10.1016/S0031-9422(02)00116-4
  6. Sarkar FH, Li Y. 2004. The role of isoflavones in cancer chemoprevention. Front Biosci 9: 2714-2724 https://doi.org/10.2741/1430
  7. Sarkar FH, Li Y. 2002. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21: 265-280 https://doi.org/10.1023/A:1021210910821
  8. Kim H, Peterson TG, Barnes S. 1998. Mechanisms of action of the soy isoflavone genistein. emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68: 1418S-1425S
  9. Constantinou A, Kiguchi K, Huberman E. 1990. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 50: 2618-2624
  10. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, Chambers AF. 1990. Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 65: 3396-3403
  11. Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK. 2005. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol 26: 1101-1109
  12. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. 2002. Genistein chemoprevention timing and mechanisms of action in murine mammary and prostate. J Nutr 132: 552S-558S
  13. Fritz WA, Coward L, Wang J, Lamartiniere CA. 1998. Dietary genistein perinatal mammary cancer prevention bioavailability and toxicity testing in the rat. Carcinogen-esis 19: 2151-2158 https://doi.org/10.1093/carcin/19.12.2151
  14. Cotroneo MS, Wang J, Fritz WA, Eltoum IE, Lamartiniere CA. 2002. Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23: 1467-1474 https://doi.org/10.1093/carcin/23.9.1467
  15. Murrill WB, Brown NM, Manzolillo PA, Zhang JX, Barnes S, Lamartiniere CA. 1996. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457 https://doi.org/10.1093/carcin/17.7.1451
  16. Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Skaar T, Russo I, Clarke R. 1999. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80: 1682-1688 https://doi.org/10.1038/sj.bjc.6690584
  17. Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R. 1999. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring. Oncol Rep 6: 1089-1095
  18. Zava DT, Duwe G. 1997. Estrogenic and antiproliferative properties of genistein and other flavanoids in human breast cancer cells in vitro. Nutr Cancer 27: 31-40 https://doi.org/10.1080/01635589709514498
  19. Bail JC, Varnat F, Nicolas JC, Habrioux G. 1998. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavanoids. Cancer Lett 130: 209-216 https://doi.org/10.1016/S0304-3835(98)00141-4
  20. Hsieh C, Santell RC, Haslam SZ, Helferich WG. 1998. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58: 3833-3838
  21. Chen WF, Huang MH, Tzang CH, Yang M, Wong MS. 2003. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta 1638: 187-196 https://doi.org/10.1016/S0925-4439(03)00082-6
  22. Li Y, Bhuiyan M, Sarkar FH. 1999. Induction of apoptosis and inhibition of C-ERBB-2 in MDA-MB-435 cells by genistein. Int J Oncol 15: 525-533
  23. Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. 2001. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22: 1667-1673 https://doi.org/10.1093/carcin/22.10.1667
  24. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. 2001. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 61: 5045-5050
  25. Zhou JR, Yu L, Mai Z, Blackburn G. 2004. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108: 8-14 https://doi.org/10.1002/ijc.11549
  26. Santell R, Kieu N, Helferich W. 2000. Genistein inhibits growth of estrogen-independent human Breast cancer cells in culture but not in athymic mice. J Nutr 130: 1665-1669
  27. Hewitt A, Singletary K. 2003. Soy extract inhibits mammary adenocarcinoma growth in syngeneic mouse model. Cancer Lett 192: 133-143 https://doi.org/10.1016/S0304-3835(02)00712-7
  28. Yuan L, Wagatsuma C, Sun B, Kim JH, Surh YJ. 2003. The role of beta-glucuronidase in induction of apoptosis by genistein combined polysaccharide (GCP) in xenogeneic mice bearing human mammary cancer cells. Ann NY Acad Sci 1010: 347-359 https://doi.org/10.1196/annals.1299.063
  29. Jin Z, MacDonald RS. 2002. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J Nutr 132: 3186-3190
  30. Gallo D, Ferlini C, Fabrizi M, Prislei S, Scambia G. 2006. Lack of stimulatory activity of a phytoestrogen-containing soy extract on the growth of breast cancer tumors in mice. Carcinogenesis 27: 1404-1409 https://doi.org/10.1093/carcin/bgi338